
The Store Is Not the Platform | How CVS’s Healthcare Strategy is Repricing Legacy Real Estate Risk
CVS Health is no longer best understood as a pharmacy retailer. The company now operates an integrated healthcare platform spanning insurance, pharmacy benefits, care delivery, medication fulfillment and consumer health engagement. That broader platform has materially changed how investors should evaluate the real estate beneath the CVS name. The distinction matters because the healthcare platform does not depend on the freestanding 11,000 to 15,000 square foot drugstore format that remains common across 1031 exchange portfolios. CVS needs prescription density, patient access and clinical service capacity. It can increasingly deliver those functions through smaller, lower-cost and more flexible locations. The platform can strengthen while the legacy box becomes less essential. For owners, that creates a format risk the market may still be underpricing. Understanding the CVS Healthcare Platform CVS Health combines businesses that historically operated as separate parts of the healthcare system. Aetna provides commercial, Medicare, Medicaid, dental and behavioral health coverage. CVS Caremark manages prescription drug benefits for employers, health plans and government clients. MinuteClinic, Oak Street Health and Signify Health extend care delivery through clinics, primary care centers, virtual platforms and patients’ homes. CVS Pharmacy provides the physical medication and consumer health infrastructure that connects those businesses to local markets. As of March 31, 2026, CVS Health operated approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care clinics, and a pharmacy benefits platform serving approximately 88 million members. The company also provided health insurance products and related services to more than 37 million people. That scale supports the credit story, but it should not be confused with support for every legacy store. Most of the value embedded in CVS’s healthcare strategy comes from access, prescription volume and patient relationships, not from maintaining a standardized freestanding retail footprint. Proximity Is the Asset, Not the Box The strategic value of CVS Pharmacy begins with proximity. CVS reports that approximately 85 percent of Americans live within 10 miles of one of its pharmacies, and the company estimates that its businesses collectively connect with approximately 185 million consumers. CVS is protecting that access network, not a fixed amount of square footage. A pharmacy counter, vaccination capacity and a focused health and wellness assortment can preserve much of the location value in a materially smaller footprint. Once investors separate location value from format value, the case for retaining every legacy box becomes less durable. Pharmacy visits also occur more frequently than most healthcare interactions, particularly for patients managing chronic conditions. That repeat traffic is strategically valuable to CVS. It does not require an 11,000 to 15,000 square foot building to capture it. CVS Is Shrinking the Retail Footprint CVS is moving toward a more flexible real estate model. Traditional stores still combine pharmacy operations with health, beauty, convenience and seasonal merchandise, which is the format most freestanding NNN investors own today. But the company now operates across a wider range of formats, and the legacy box is no longer the only template for growth. CVS operates pharmacies inside Target and other retailers, culturally focused formats such as CVS Pharmacy y Mas, and locations integrated with MinuteClinic or Oak Street Health services. In 2026, the company also began introducing smaller pharmacy-only locations of roughly 3,000 square feet centered on prescriptions, immunizations and pharmacist services. CVS announced plans for nearly 20 of these apothecary-style locations during the year, including sites in Chicago, Houston, Detroit, Brooklyn, Roxbury and other markets. The direction is consistent with the broader portfolio reset. CVS has closed roughly 1,100 net store locations over the past four years while testing a smaller format that preserves healthcare access with less occupancy cost and less capital intensity. For real estate investors, that is direct evidence that the company can separate the value of a market from the value of the legacy building serving it. Tennessee Makes the Strategic Tradeoff Clear Tennessee’s recent PBM reform provides one of the clearest examples of how CVS prioritizes the broader healthcare platform relative to its physical store network. The state’s FAIR Rx Act restricts companies from simultaneously controlling a pharmacy, a pharmacy benefit manager, and a health insurer, directly challenging CVS Health’s vertically integrated structure across CVS Pharmacy, Caremark, and Aetna. CVS responded by warning that the legislation could result in the closure of all of its Tennessee pharmacies, along with more than 25 MinuteClinic locations. The company subsequently challenged the law in federal court. Rather than suggesting it would separate from Caremark or Aetna to preserve the existing retail footprint, CVS has framed the potential consequence as the loss of its Tennessee pharmacy locations. The economics of the broader company help explain why that distinction matters. CVS’s Health Care Benefits and Health Services segments generate significantly more operating income than its Pharmacy & Consumer Wellness segment. Health Services includes CVS Caremark and the company’s care delivery businesses, while Health Care Benefits includes Aetna. The comparison reinforces the growing importance of CVS’s healthcare and PBM operations relative to its traditional retail footprint. Format Risk Is Becoming Real Estate Risk CVS Health’s segment reporting shows sustained pressure on the front-store retail business, while pharmacy reimbursement and PBM regulation continue to tighten operating economics. The FTC consent order involving Caremark and state-level PBM legislation in markets including Arkansas, Tennessee and Oklahoma increase the incentive to operate more efficiently. A smaller, clinically focused footprint fits that objective without weakening the healthcare platform. For owners of legacy freestanding CVS stores, the issue becomes most relevant at lease rollover. At the end of a 15 to 20-year lease term, CVS does not need to choose between remaining in the market and leaving it. The company can remain in the trade area while reducing its footprint from 12,000 square feet to 3,000 square feet. That flexibility introduces a credible non-renewal risk for properties where the existing box is larger or more expensive than the operating model requires. The 1031 market has historically priced CVS net-lease assets primarily on tenant credit and remaining lease term. That framework made more sense when the standardized freestanding box was the dominant operating format. It is less complete today. If CVS can deliver comparable healthcare access through a much smaller location, investors need to underwrite building-level renewal probability alongside corporate credit. The roughly 100-basis-point cap-rate spread between CVS and Walgreens reflects a credit differential, but it may not fully account for format risk. Implications for Owners CVS should increasingly be underwritten as a healthcare occupier, but the analysis still needs to occur at the property level. Prescription density, patient access, local market position, rent basis, remaining options and alternative-use value matter more than broad assumptions about the strength of the corporate platform. A strong CVS credit profile does not eliminate renewal risk for an oversized or economically inefficient location. Near-term lease expirations deserve the most scrutiny. CVS can preserve market access without preserving the existing building, and owners should price that risk before rollover.

Brandon Doblie
Associate



























